Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Code:
NCT07071155
Conditions
Chronic Myelomonocytic Leukemia
Myelodysplastic Syndromes
Myeloproliferative Overlap Neoplasms
Chronic Neutrophilic Leukemia
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Momelotinib
Azacitidine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-12. This information was provided to ClinicalTrials.gov by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins on 2026-03-27.